{
    "persona": "conservative",
    "model": "mixtral:8x7b-instruct-v0.1-q6_K",
    "topic": "healthcare",
    "language": "English",
    "text": "Exciting news for migraine sufferers! Atogepant shows promising long-term effectiveness in reducing monthly migraine days by 8.5 on average. A victory for patient care and evidence-based medicine.",
    "retrieved_source": "https://www.medscape.com/viewarticle/first-long-term-data-atogepant-migraine-prevention-2024a10007cb",
    "annotation": {
        "topic": null,
        "persona": null,
        "authenticity": null
    },
    "id": "8c75fb8ba9cb90abd3595e6801c88d97f7b2d429c7621906"
}